CTEV Stock Summary and Trading Ideas (Claritev Class A | NYSE:CTEV)

Claritev Corp is a healthcare technology, data, and insights company focused on improving transparency, affordability, and quality. The company provides tech-enabled solutions and services to interpret clients' needs and customize solutions that combine its payment integrity, network-based, and analytics-based services. The company's focus is on being a value-added provider of data analytics and technology-enabled end-to-end cost management, payment, and revenue integrity solutions to the U.S. healthcare industry.

Claritev Class A trades on the NYSE stock market under the symbol CTEV.

As of September 9, 2026, CTEV stock price declined to $36.29 with 116,393 million shares trading.

CTEV has a beta of 2.32, meaning it tends to be more sensitive to market movements. CTEV has a correlation of 0.04 to the broad based SPY ETF.

CTEV has a market cap of $615.02 million. This is considered a Small Cap stock.

Last quarter Claritev Class A reported $257 million in Revenue and -$3.49 earnings per share. This beat revenue expectation by $12 million and missed earnings estimates by -$3.73.

The top ETF exchange traded funds that CTEV belongs to (by Net Assets): VTI, FNDA, DWAS, VXF, SCHA.

CTEV has underperformed the market in the last year with a price return of -49.9% while the SPY ETF gained +18.4%. However, in the short term, CTEV had mixed performance relative to the market. It has outperformed in the last 3 months, returning +28.0% vs +3.7% return in SPY. But in the last 2 weeks, CTEV shares have been beat by the market, returning -3.4% compared to an SPY return of -0.5%.

CTEV support price is $35.46 and resistance is $39.96 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CTEV shares will trade within this expected range on the day.